Caitlyn MillerResearcher at Stanford UniversitySpeaker
Profile
Caitlyn Miller, PhD, co-founder and CEO of TwoStep Therapeutics, is dedicated to the company’s mission of bringing innovative targeted therapies to patients. Dr. Miller received her PhD in Bioengineering from Stanford University in the labs of Dr. Carolyn Bertozzi and Dr. Jennifer Cochran. During her PhD and postdoctoral work, Dr. Miller played a pivotal role in advancing technology that is now integrated into TwoStep’s therapeutic pipeline. Dr. Miller then joined the Stanford Innovative Medicines Accelerator as an Entrepreneur-In-Residence, where she spearheaded the efforts to launch TwoStep Therapeutics.
Agenda Sessions
Expanding the Reach of Targeted Cancer Therapy Using Multispecific Peptide-Drug Conjugates
, 8:45amView Session